Перейти к содержанию

Bio-techne Corp (TECH) stock: revenue, earnings & dividend

Bio-techne Corp (TECH, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener TECH · Nasdaq Pharma & Biotech US-MN

Key figures

Fiscal year
2025
Revenue
1.22 bn $
Revenue growth
5.2 %
Revenue growth 5y (p.a.)
10.6 %
Net income
73.4 m $
Net margin
6 %
Operating margin
8.4 %
Earnings per share (diluted)
0.46 $
Dividend per share
0.32 $
Payout ratio
69.6 %
Consecutive dividend years
17 years
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
0 %
Total assets
2.52 bn $
Equity
2.01 bn $
Equity ratio
79.7 %
Return on equity
3.7 %
Cash
173 m $
Operating cash flow
288 m $
Free cash flow
257 m $
Shares outstanding
157,055,564

History

Revenue by fiscal year

2016 499 m $
2017 563 m $
2018 643 m $
2019 714 m $
2020 739 m $
2021 931 m $
2022 1.11 bn $
2023 1.14 bn $
2024 1.16 bn $
2025 1.22 bn $

Net income by fiscal year

2016 104 m $
2017 76.1 m $
2018 126 m $
2019 96.1 m $
2020 229 m $
2021 140 m $
2022 272 m $
2023 285 m $
2024 168 m $
2025 73.4 m $

Dividend per share

2016 0.32 $
2017 0.32 $
2018 0.32 $
2019 0.32 $
2020 0.32 $
2021 0.32 $
2022 0.32 $
2023 0.32 $
2024 0.32 $
2025 0.32 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.22 bn $73.4 m $0.46 $0.32 $288 m $
20241.16 bn $168 m $1.05 $0.32 $299 m $
20231.14 bn $285 m $1.76 $0.32 $254 m $
20221.11 bn $272 m $1.66 $0.32 $325 m $
2021931 m $140 m $0.87 $0.32 $352 m $
2020739 m $229 m $1.46 $0.32 $205 m $
2019714 m $96.1 m $0.62 $0.32 $182 m $
2018643 m $126 m $0.83 $0.32 $170 m $
2017563 m $76.1 m $0.51 $0.32 $144 m $
2016499 m $104 m $0.70 $0.32 $144 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)